GLP-1 risks While GLP-1 drugs are generally safe, especially for people with diabetes or obesity, they can cause side effects like nausea or, in some cases, loss of muscle mass, which is a concern for older adults
Conditions involving intestinal inflammation, barrier dysfunction, or ulceration may respond to the peptide reparative effects, particularly when administered orally for direct tissue contact
We publish what we'd want to read if we were figuring this out for the first time Latest Hormones & Metabolism FDA Advisory Committee Votes to Ease Peptide Restrictions: What the July 2026 Vote on BPC-157, KPV, TB-500, and MOTS-c Actually Means An FDA advisory committee voted on July 23, 2026 to recommend easing restrictions on four peptides BPC-157, KPV, TB-500, and MOTS-c
Intramuscular administration of vitamin B12 is often preferred for its rapid improvement in patients with severe deficiency or severe neurological symptoms
Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV